|Videos|June 6, 2020

Jason Pogue, PharmD: Preventing Another COVID-19 Data Disaster

Jason Pogue, PharmD, BCPS, BCIDP, speaks about the state of publishing during the COVID-19 pandemic.

Segment Description: Jason Pogue, PharmD, BCPS, BCIDP, clinical pharmacist and professor in infectious diseases at the University of Michigan College of Pharmacy, speaks with Contagion about the state of publishing during the COVID-19 pandemic.

The debate has been complicated in recent days, after The New England Journal of Medicine and The Lancet had authors issue retractions of articles based on a potentially faulty data source.

The contested articles came from a database which cannot be verified. The results also showed what some view as an unrealistic level of harm from the drug, even among hydroxychloroquine skeptics. A different publication, on use of the drug for out-patient prophylaxis, has offered less contested insight.


Related to this article

Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.